Remove unsupported claims about the schedule being distinct from CDC's recommendations.
Background
Maternal immunization is crucial for protecting both mothers and infants from vaccine-preventable diseases, which can lead to severe health outcomes. The updated ACOG schedule aims to provide clear guidance for healthcare providers in the U.S. regarding vaccination during pregnancy. The differences from CDC guidelines highlight the evolving nature of vaccine recommendations in obstetric care.
Data Highlights
No numerical data provided in the source material.
Key Findings
ACOG recommends four routine maternal vaccines: influenza, COVID-19, Tdap, and RSV.
Influenza and COVID-19 vaccines can be administered at any gestational age.
Tdap vaccination is advised during each pregnancy at 27-36 weeks of gestation.
Pfizer’s Abrysvo is the only recommended RSV vaccine for maternal vaccination.
Specific vaccines are suggested based on individual comorbidities or risk factors.
HPV vaccination should be initiated postpartum or while breastfeeding, not during pregnancy.
Clinical Implications
Healthcare providers should utilize the ACOG maternal immunization schedule to discuss vaccination with their patients. The schedule serves as a tool to enhance patient education on the importance of immunizations during pregnancy.
Conclusion
The 2026 maternal immunization schedule by ACOG provides essential guidance for obstetric care, emphasizing the importance of vaccination for maternal and infant health.
A nationwide birth cohort found lower odds of short sleep at 1 year among infants breastfed during the first 6 months of life, regardless of formula supplementation.
A Beyond the Guidelines discussion highlighted uncertainty around gastrointestinal evaluation and intravenous iron use in premenopausal women with iron deficiency.
More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.
